New research found immunoglobulin-binding protein 1 (IGBP1) to be a valid biomarker for lupus nephritis (LN, lupus-related ...
The Lupus Foundation of America is pleased to announce the recipients of the 2022 Gary S. Gilkeson Career Development Award (CDA).
New research finds the biologic therapy, telitacicept, effective, well tolerated, and safe as a potential treatment of lupus, especially lupus nephritis. Biologic therapies use substances made from ...
Each year, the National Lupus Advocacy Summit brings together the entire lupus community in pursuit of our shared goal: a ...
Each May rally your family, friends and community to raise funds and awareness of the invisible physical, emotional and financial impact of lupus. Help us continue to advocate, educate, support and ...
Lupus is an unpredictable and misunderstood disease that ravages different parts of the body. It is difficult to diagnose, hard to live with, a challenge to treat, and can be fatal. The resources on ...
We support everyone affected by lupus. Whether you are living with lupus, a parent, spouse or loved one - we're your partner on this journey. The Lupus Foundation of America provides education and ...
Dr. Rachel Randell is from Durham, North Carolina. She completed medical school at the University of North Carolina at Chapel Hill, where her clinical rotations sparked an interest in caring for ...
Effective treatment of high blood pressure is an important measure in preventing heart attacks and strokes, which occur more commonly in people with lupus. In addition, high blood pressure can ...
The majority of people with lupus are sensitive to ultraviolet light. This sensitivity is typically from ultraviolet B (UVB) rays, but some individuals can also be sensitive to ultraviolet A (UVA) ...